Related Experiment Videos
Nemo-like kinase induces apoptosis in DLD-1 human colon cancer cells
Jun Yasuda1, Akira Tsuchiya, Tesshi Yamada
1Cancer Transcriptome Project, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. jyasuda@ncc.go.jp
Abstract:
Deregulation of Wnt/beta-catenin signaling is thought to play a critical role in human carcinogenesis. Nemo-like kinase (NLK) is an evolutionarily conserved serine/threonine kinase that suppresses beta-catenin/T-cell factor (TCF) complex transcriptional activity through phosphorylation of TCF. Since NLK may be a tumor suppressor as a negative regulator of Wnt/beta-catenin pathway, we established tetracycline-inducible NLK and its kinase-negative mutant expression in DLD-1 human colon cancer cells to analyze the effect of NLK on cell growth and viability. The induction of wild-type NLK in DLD-1 cells caused suppression of cell growth whereas the kinase-negative mutant did not. Flow cytometry indicated that NLK expression increased the number of apoptotic cells but did not induce obvious cell cycle arrest. Apoptosis induction by wild-type NLK was confirmed using TUNEL assays. Our results suggest that overexpression of NLK may have targets other than TCF for induction of apoptosis in human colon carcinoma cells.
Insights
Nemo-like kinase (NLK) suppresses colon cancer cell growth by inducing apoptosis. Overexpression of wild-type NLK, but not its inactive mutant, reduced cell viability, suggesting NLK
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Aberrant Wnt/beta-catenin signaling is a key factor in human cancer development.
- Nemo-like kinase (NLK) is a serine/threonine kinase that negatively regulates Wnt/beta-catenin signaling by phosphorylating TCF, thus inhibiting downstream gene transcription.
- NLK's role as a potential tumor suppressor warrants further investigation in the context of colon cancer.
Purpose of the Study:
- To investigate the effect of NLK expression on the growth and viability of DLD-1 human colon cancer cells.
- To determine if NLK's kinase activity is essential for its effects on colon cancer cell proliferation and survival.
- To explore the mechanisms by which NLK influences colon cancer cell fate, including apoptosis and cell cycle progression.
Main Methods:
- Establishment of tetracycline-inducible expression systems for wild-type NLK and a kinase-negative NLK mutant in DLD-1 colon cancer cells.
- Assessment of cell growth and viability following NLK induction.
- Flow cytometry analysis to evaluate cell cycle distribution and apoptosis.
- TUNEL assays to confirm apoptosis induction.
Main Results:
- Induction of wild-type NLK significantly suppressed cell growth and viability in DLD-1 cells.
- The kinase-negative NLK mutant did not exhibit significant effects on cell growth or viability, indicating the importance of NLK's kinase activity.
- NLK expression led to an increase in apoptotic cells, as confirmed by flow cytometry and TUNEL assays, without causing significant cell cycle arrest.
Conclusions:
- Overexpression of wild-type NLK acts as a tumor suppressor in human colon cancer cells by inducing apoptosis.
- NLK's tumor-suppressive function is dependent on its kinase activity.
- NLK may induce apoptosis through targets other than TCF in colon carcinoma cells, suggesting broader regulatory roles.